Bulis Veronica Sanchez 4

What Happened
Veronica Sanchez Bulis, Vice President and Corporate Controller of Lyell Immunopharma (LYEL), had two related transactions dated Feb 10, 2026. She was granted 8,750 restricted stock units (RSUs) (award, $0.00 per share) and 254 shares were disposed of at $23.12 each for total proceeds of $5,872. The sale was an automatic share sale to cover tax withholding tied to vested RSUs (not a discretionary open-market sell).

Key Details

• Transaction date: 2026-02-10; filing date: 2026-02-11 (timely filed).
• Sale: 254 shares at $23.12 — proceeds $5,872.
• Award: 8,750 restricted stock units granted at $0.00 (RSUs).
• Shares owned after transaction: not specified in the filing.
• Footnotes:
  • F1: RSUs granted under the Issuer's 2021 Equity Incentive Plan. 12.5% vest on Aug 9, 2026, then an additional 1/16th of the total vests quarterly thereafter, subject to continued service.
  • F2: The 254 shares were automatically sold to cover tax withholding from settlement of vested RSUs.
• No 10b5‑1 plan or late‑filing flag noted.

Context
RSU grants are common employee compensation; the automatic sale to cover tax withholding is routine and does not necessarily indicate a discretionary decision to sell shares. For retail investors, purchases by insiders often carry more informational weight than routine withholding sales; this filing primarily reflects compensation settlement rather than an active investment choice.